Viridian Therapeutics, Inc. (VRDN) Ownership

$17.04

$0.09 (-0.53%)
Last update: 04:00 PM EST
Day's range
$16.78
Day's range
$17.39

Viridian Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/12/2025 12.22 M $164.77 M   2.87% 15.03%
BLACKROCK, INC. 05/02/2025 5.71 M $76.95 M   -0.88% 7.02%
DEEP TRACK CAPITAL, LP 05/15/2025 5.38 M $72.53 M   18.96% 6.61%
KYNAM CAPITAL MANAGEMENT, LP 05/15/2025 4.70 M $63.36 M   41.30% 5.78%
VANGUARD GROUP INC 05/09/2025 4.56 M $61.51 M   -0.70% 5.61%
VR ADVISER, LLC 05/15/2025 3.88 M $52.34 M   0.00% 4.77%
COMMODORE CAPITAL LP 05/15/2025 3.60 M $48.53 M   50.00% 4.43%
STATE STREET CORP 05/15/2025 2.87 M $38.63 M   -18.65% 3.52%
TANG CAPITAL MANAGEMENT LLC 05/15/2025 2.79 M $37.65 M   12.03% 3.43%
NOVO HOLDINGS A/S 05/15/2025 2.25 M $30.33 M   0.01% 2.77%
PARADIGM BIOCAPITAL ADVISORS LP 05/15/2025 2.10 M $28.24 M   15.11% 2.58%
MAVERICK CAPITAL LTD 05/15/2025 2.06 M $27.79 M   0.36% 2.53%
ALLIANCEBERNSTEIN L.P. 05/15/2025 2.02 M $27.25 M   -11.60% 2.49%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 1.72 M $23.20 M   3.71% 2.12%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 1.69 M $22.76 M   27.23% 2.08%
EVERSEPT PARTNERS, LP 05/15/2025 1.38 M $18.57 M   76.63% 1.69%
LOOMIS SAYLES & CO L P 05/14/2025 1.37 M $18.47 M   -2.14% 1.68%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2025 1.27 M $17.13 M   -32.27% 1.56%
PICTET ASSET MANAGEMENT HOLDING SA 05/05/2025 1.25 M $16.83 M   0.00% 1.54%
GOLDMAN SACHS GROUP INC 06/27/2025 1.23 M $16.60 M   33.80% 1.51%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 1.11 M $15.02 M   -33.26% 1.37%
MARSHALL WACE, LLP 05/15/2025 1.08 M $14.61 M   100.00% 1.33%
PARKMAN HEALTHCARE PARTNERS LLC 05/15/2025 1.06 M $14.35 M   -2.13% 1.31%
VIVO CAPITAL, LLC 05/12/2025 982.58 K $13.25 M   0.00% 1.21%
CANDRIAM S.C.A. 05/14/2025 880.43 K $11.87 M   20.41% 1.08%
WOODLINE PARTNERS LP 05/15/2025 813.65 K $10.97 M   0.00% 1.00%
GREAT POINT PARTNERS LLC 05/15/2025 750.00 K $10.11 M   0.00% 0.92%
NORTHERN TRUST CORP 05/13/2025 702.52 K $9.47 M   1.21% 0.86%
PERCEPTIVE ADVISORS LLC 05/15/2025 659.66 K $8.89 M   -55.62% 0.81%
ROSALIND ADVISORS, INC. 05/14/2025 595.00 K $8.02 M   100.00% 0.73%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 565.96 K $7.63 M   -1.58% 0.70%
VICTORY CAPITAL MANAGEMENT INC 05/02/2025 552.85 K $7.45 M   34.70% 0.68%
FISHER ASSET MANAGEMENT, LLC 05/14/2025 537.02 K $7.24 M   3.67% 0.66%
UBS GROUP AG 05/13/2025 504.19 K $6.80 M   -1.54% 0.62%
YIHENG CAPITAL MANAGEMENT, L.P. 05/16/2025 500.26 K $6.74 M   -33.32% 0.62%
IKARIAN CAPITAL, LLC 05/15/2025 494.95 K $6.67 M   5.32% 0.61%
OCTAGON CAPITAL ADVISORS LP 05/16/2025 450.00 K $6.07 M   -48.28% 0.55%
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. 05/06/2025 423.27 K $5.71 M   0.00% 0.52%
DEUTSCHE BANK AG\ 05/09/2025 396.81 K $5.35 M   -1.51% 0.49%
AFFINITY ASSET ADVISORS, LLC 05/14/2025 390.00 K $5.26 M   144.34% 0.48%
RICE HALL JAMES & ASSOCIATES, LLC 05/01/2025 362.89 K $4.89 M   579.89% 0.45%
PANAGORA ASSET MANAGEMENT INC 05/15/2025 354.74 K $4.78 M   40.20% 0.44%
MORGAN STANLEY 05/15/2025 341.80 K $4.61 M   -53.76% 0.42%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 320.30 K $4.32 M   -13.71% 0.39%
RAYMOND JAMES FINANCIAL INC 05/13/2025 318.24 K $4.29 M   1.42% 0.39%
JPMORGAN CHASE & CO 05/12/2025 298.55 K $4.02 M   -1.90% 0.37%
MILLENNIUM MANAGEMENT LLC 05/15/2025 297.97 K $4.02 M   -18.58% 0.37%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 249.17 K $3.36 M   11.00% 0.31%
05/12/2025 248.63 K $3.35 M   100.00% 0.31%
TWO SIGMA INVESTMENTS, LP 05/15/2025 222.40 K $3.00 M   -47.61% 0.27%

Viridian Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 198 institutional investors and hedge funds held shares of Viridian Therapeutics, Inc.. The most heavily invested institutionals were:

FMR LLC: 12.22 M

BlackRock, Inc.: 5.71 M

Deep Track Capital, LP: 5.38 M

Kynam Capital Management, LP: 4.7 M

VANGUARD GROUP INC: 4.56 M

VR Adviser, LLC: 3.88 M

107.04% of Viridian Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 93.91 M shares in the last 24 months. This purchase volume represents approximately $1.60 B in transactions.